In this episode of the “CURE® Talks Cancer” podcast, Dr. Thomas Marron of the Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai in New York discusses the exciting future of cancer vaccines.
Researchers have been working to develop an exciting new option for patients with cancer: personalized vaccines that teach the body to recognize cancer cells and help the immune system learn to attack the cancer.
In this episode of the “CURE® Talks Cancer” podcast, Dr. Thomas Marron, director of the early phase trials unit at The Tisch Cancer Institute and assistant professor of medicine at Icahn School of Medicine at Mount Sinai in New York, explains how personalized cancer vaccines work, the latest research on them and what we can expect to see down the road.
“What vaccines are really about is not so much the cancer outsmarting the immune system, but the vaccines are really helpful for patients where their immune system hasn't yet been taught what to be on the lookout for,” said Marron.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.